Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan in Relapsed/Refractory Non-Hodgkin's Lymphoma
NCT00003245Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 1998
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in non-Hodgkin lymphoma (NHL), sponsored by University of Texas MD Anderson Cancer Center. Started Feb 1998; status: completed.
02
Drugs
irinotecan
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00003245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003245.